Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Baxter
Mallinckrodt
Johnson and Johnson
Express Scripts

Litigation • Annual Sales • Drugs in Development • Drug Prices • Patents

Make Better Decisions

  Start Trial


NEW Daily email alerts on drug approvals, patents, litigation, and more…

See Plans and Pricing

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Drug Profile

Global Biopharmaceutical Business Intelligence

  • Identify and evaluate commercial opportunities
  • Branded and generic drug pipeline forecasting
  • Anticipate future revenue events
  • Identify API and finished drug product suppliers
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Track 505(b)(2) entrants

Monitor 505(b)(2) activity

  • Anticipate 505(b)(2) approvals
  • Track OTC-switches, new formulations, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Drug synonyms

Prior art search support

  • Exhaustive list of synonyms to aid in your patent searches
  • Clinical trial histories to support patent challenges
  • Find prior art in expired patents
  • Search for claims across all patents
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track drugs in development and explore new indications for existing drugs

Clients in 67 Countries

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Moodys
AstraZeneca
Colorcon
Harvard Business School